ine the front-page headlines in the New York Times. But coming in the wake of the embarrassing retraction of several highly publicized psychiatric linkage papers (schizophrenia on chromosome 5, anyone?), my colleagues opted to reject the paper without peer review. It was subsequently snapped up by the New England Journal of Medicine.prominent geneticists, I was dismayed to learn that at least two publishers were exploring a similar venture: Hunt Willard and my former PhD advisor, Kay E. Davies (no relation), were launching a monthly journal through Oxford University Press called Human Molecular Genetics. Next, Haig Kazazian said that Wiley, too, was jumping on the bandwagon. He even had the temerity to suggest that Nature had missed the boat, although personally I didn't see Nature had missed the boat, although personally I didn't see Nature the mass appeal of a journal entitled Human Mutation.
But researchers were clamoring for a high profile, rapid-publication alternative to Genomics and Genomics and Genomics The American Journal of Human Genetics. Nature Genetics was sounding better and better, particuNature Genetics was sounding better and better, particuNature Genetics larly with the enthusiastic backing of Nature's then Washington bureau chief and deputy editor, Barbara Culliton (who went on to launch Nature Medicine and run the Genome News Network Nature Medicine and run the Genome News Network Nature Medicine at Celera). The clincher came in October 1991, when we invited a few geneticists to lunch during the American Society of Human Genetics conference in Washington, D.C. As I labored to explain how our new publication (and the community) would prosper from the referral of worthy but rejected manuscripts from Nature, one up-and-coming geneticist threw up his hands and said: "Look, it's a great idea, but if you're going to do this, you should make it the best possible journal it can be, even competing with Nature if necessary." It's possible his language was a little more colorful, but in any event, it would not be the last time we heard from one Eric Lander.
During Thanksgiving week, 1991, Maddox, Waltham, Robertson and I met in Manhattan to make the momentous decision. There would be no launch without the blessing of Nicholas Byam Shaw, Macmillan's urbane chairman, but he loved the plan. He issued just two vetoes-there would be no page charges and no editorial board-neither, he said, was part of the Nature tradition.
Nature tradition. Nature Nature Genetics received the green light, with just four months to pull the Genetics received the green light, with just four months to pull the Genetics first issue together.
The inaugural issue of Nature Genetics in April 1992 exceeded all Nature Genetics in April 1992 exceeded all Nature Genetics our expectations, crammed with exciting papers from prestigious authors-Francis Collins, Bert Vogelstein, Grant Sutherland, Doug Wallace and J. Craig Venter, to name a few. The only intervention from Maddox came as we went to press, when he opted to write the inaugural editorial himself. It was a good decision-Maddox outlined the key areas the journal would target, and it is remarkable how well it has held up. (Not surprising, from the author of What Remains to be Discovered.)
After 12 months flying solo, Nature Genetics finally recruited its Nature Genetics finally recruited its Nature Genetics first assistant editor. Culliton and I arranged to interview Adrian Ivinson at the Oriental Club in London, only for a dumbfounded Culliton to be informed that club rules barred women from the library. We convened in a hallway and got our man. Ivinson thrived as assistant editor-although we were briefly threatened with a lawsuit following a typically strident editorial on the forensic genotyping of the last Tsar's remains-and would become publisher of the growing family of Nature sister journals.
Our first impact factor from the Institute of Scientific Information (ISI) proved that Nature Genetics was reaching an Nature Genetics was reaching an Nature Genetics audience far beyond its modest early circulation. Indeed, for two consecutive years in the mid-1990s, Nature Genetics garnered the Nature Genetics garnered the Nature Genetics highest impact factor for any research journal in any discipline, topping Nature, Science and even Science and even Science Cell. We were flattered, but perplexed by how seriously international scientists took the results. European researchers could quote me the journal's latest impact factor to two decimal places, while labs I toured in Japan prominently displayed the latest ISI top ten rankings.
Relations with Nature were cordial enough, despite the occaNature were cordial enough, despite the occaNature sional mishap. We were thrilled when Jean-Louis Mandel sent us his paper on the cloning of the gene for X-linked adrenoleukodystrophy (the disorder featured in the movie Lorenzo's Oil). Just as we were readying the acceptance letter, I received a call from a groveling Nature editor in London, stating that Nature editor in London, stating that Nature Nature had reversed its Nature had reversed its Nature original decision and elected to publish the paper after Mandel's belated appeal. We even had the gratification of seeing a couple of our rejected papers end up in Cell, prompting momentary anxiety as to whether we'd made some catastrophic mistake.
The press naturally feasted on the 'Gene of the Month' fever that Nature Genetics helped to promote. Spinocerebellar ataxia, Nature Genetics helped to promote. Spinocerebellar ataxia, Nature Genetics novelty seeking and hemochromatosis were just a few highlights. Heeding Maddox's advice and the "Niven factor," we occasionally published papers more for their undisputable general interest than their ostensible scientific advance. For example, we published the refined mapping of the gene for X-linked generalized hypertrichosis largely because of the fascinating hairy phenotype, not because the authors were close to finding the gene. This prompted angry letters from several aggrieved geneticists protesting our editorial decision. But a stunning story on hirsutism and atavistic mutations in the New York Times by Natalie Angier convinced me we'd done New York Times by Natalie Angier convinced me we'd done New York Times the right thing.
It was a privilege to help create something so thrilling and to interact with such a talented and vibrant community of geneticists-my principal reason for moving into science publishing in the first place. Those that have followed me since 1997-Barbara Cohen (now with PLoS), Bette Phimister (New England Journal of Medicine) and the current editorial team have done a superb job of broadening the journal's horizons, making it a must-read for a much wider community. The field of genetics moves at breathtaking pace, but Nature Genetics seems set to nurture those changes Nature Genetics seems set to nurture those changes Nature Genetics better than ever.
